Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature

by Marie-Laure Kürzinger, Ludivine Douarin, Ievgeniia Uzun, Chantal El-Haddad, William Hurst, Juhaeri Juhaeri, Stéphanie Tcherny-Lessenot
Published 2020-12-01